SCHEMBL21369883

SCHEMBL21369883

c1ccc(-c2ccc(-c3cc(-c4ccccc4)nc(-c4cc(-c5cc6ccccc6c6ccccc56)cc(-n5c6ccccc6c6ccc(-c7ccccc7)cc65)c4)n3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.36
MEN1 O00255 6/20 0.35
KMT2A Q03164 6/20 0.35
ALDH1A1 P00352 6/20 0.35
MAPT P10636 6/20 0.35
HPGD P15428 6/20 0.35
NTSR1 P30989 1/20 0.35
KDM4E B2RXH2 5/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ATM Q13315 1/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ACACA Q13085 1/20 0.33
LMNA P02545 2/20 0.32
GLA P06280 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
DHODH Q02127 1/20 0.32
CYP1A1 P04798 1/20 0.31
CYP1B1 Q16678 1/20 0.31
ADORA2A P29274 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21369881 1.00 CYP11B1 (0.36) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL21369955 0.98 CYP11B1 (0.34) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL21370317 0.98 MEN1 (0.36) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL21370319 0.98 CYP11B1 (0.34) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL21369810 0.97 KDM4E (0.38) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL21370205 0.97 MEN1 (0.37) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL21370202 0.97 MEN1 (0.37) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL21369800 0.95 CYP11B1 (0.39) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL21370318 0.95 CYP1A1 (0.40) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL21369679 0.94 CYP11B1 (0.35) CYP11B1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME SOULBRAIN CO., LTD. (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 CYP11B1 37/4885MEN1 307/4885KMT2A 1401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.